| Name |
|---|
OPA3 Geneoptic atrophy 3 (autosomal recessive, with chorea and spastic paraplegia) The mouse ortholog of this protein co-purifies with the mitochondrial inner membrane. Mutations in this gene have been shown to result in 3-methylglutaconic aciduria type III and autosomal dominant optic atrophy and cataract. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2009] |
SPG27 Genespastic paraplegia 27 (autosomal recessive) |
SPG25 Genespastic paraplegia 25 (autosomal recessive, with disc herniation) |
SPG24 Genespastic paraplegia 24 (autosomal recessive) |
SPG21 Genespastic paraplegia 21 (autosomal recessive, Mast syndrome) The protein encoded by this gene binds to the hydrophobic C-terminal amino acids of CD4 which are involved in repression of T cell activation. The interaction with CD4 is mediated by the noncatalytic alpha/beta hydrolase fold domain of this protein. It is thus proposed that this gene product modulates the stimulatory activity of CD4. Mutations in this gene are associated with autosomal recessive spastic paraplegia 21 (SPG21), also known as mast syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2014] |
SPG23 Genespastic paraplegia 23 (autosomal recessive) |
SPG20 Genespastic paraplegia 20 (Troyer syndrome) This gene encodes a protein containing a MIT (Microtubule Interacting and Trafficking molecule) domain, and is implicated in regulating endosomal trafficking and mitochondria function. The protein localizes to mitochondria and partially co-localizes with microtubules. Stimulation with epidermal growth factor (EGF) results in protein translocation to the plasma membrane, and the protein functions in the degradation and intracellular trafficking of EGF receptor. Multiple alternatively spliced variants, encoding the same protein, have been identified. Mutations associated with this gene cause autosomal recessive spastic paraplegia 20 (Troyer syndrome). [provided by RefSeq, Nov 2008] |
SPG36 Genespastic paraplegia 36 (autosomal dominant) |
SPG45 Genespastic paraplegia 45 (autosomal recessive) |
SPG41 Genespastic paraplegia 41 (autosomal dominant) This locus was defined in a Chinese family. Nineteen individuals were genotyped and the interval was defined between D11S1324 and D11S1933. [provided by RefSeq, Feb 2010] |
SPG7 Genespastic paraplegia 7 (pure and complicated autosomal recessive) This gene encodes a mitochondrial metalloprotease protein that is a member of the AAA family. Members of this protein family share an ATPase domain and have roles in diverse cellular processes including membrane trafficking, intracellular motility, organelle biogenesis, protein folding, and proteolysis. Mutations in this gene cause autosomal recessive spastic paraplegia 7. Two transcript variants encoding distinct isoforms have been identified. [provided by RefSeq, Mar 2014] |
SPG9 Genespastic paraplegia 9 (autosomal dominant) |
SPG11 Genespastic paraplegia 11 (autosomal recessive) The protein encoded by this gene is a potential transmembrane protein that is phosphorylated upon DNA damage. Defects in this gene are a cause of spastic paraplegia type 11 (SPG11). Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2009] |
SPG16 Genespastic paraplegia 16 (complicated, X-linked recessive) |
SPG18 Genespastic paraplegia 18 (autosomal dominant) |
SPG19 Genespastic paraplegia 19 (autosomal dominant) |
SPG14 Genespastic paraplegia 14 (autosomal recessive) |
SPOAN Genespastic paraplegia, optic atrophy, and neuropathy |
SPG34 Genespastic paraplegia 34 (autosomal dominant) |
SPG37 Genespastic paraplegia 37 (autosomal dominant) |
SPG38 Genespastic paraplegia 38 (autosomal dominant, Silver syndrome) |
SPG3B Genespastic paraplegia 3B |
SPG32 Genespastic paraplegia 32 (autosomal recessive) |
SPG29 Genespastic paraplegia 29 (autosomal dominant) |
SPG5B Genespastic paraplegia 5B (autosomal recessive) |